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Abstract
Sonoporation is a method for inducing a transient increase in the permeability of cell
membranes to otherwise impermeable compounds using ultrasound. This technique has
therapeutic potential as it allows for localized delivery of therapeutic agents in a non-
invasive and non-cytotoxic manner. The discovery and testing of potential therapeutic
agents that can be delivered using this technique requires performing studies on cell
cultures in vitro. This thesis presents a prototype sonoporation device which aims to
reduce the time and expertise required to perform sonoporation on adherent monolayer
cell cultures.
First, a prototype sonoporation device was designed and constructed. The device con-
sisted of an array of six ultrasound transducers affixed below a cell culture stage. The
six transducers were each constructed and electrically matched to 50 Ω at an operating
frequency of 1 MHz. The acoustic near-field of each transducer was characterized using hy-
drophone scanning and the distance from the transducer at which the plane perpendicular
to the beam path was most homogeneous was determined. The mean(±s.d.) treatment
distance was 15.9(±0.67) mm and the mean -3 dB width was 1.97(±0.22) mm. The elec-
trical power required to produce 0.7 MPa on this plane was found for each transducer.
The mean(±s.d.) electrical power was 101(±12.2) W.
Next, the prototype device was experimentally validated. Sonoporation was performed
on cervical carcinoma-derived SiHa cells with 70-80% confluency at media temperatures
of 37°C, 39.5°C, and 42°C. Pulsed ultrasound of 1 MHz, 4.8% duty cycle, 1.6 kHz pulse
repetition frequency, and 0.7 MPa peak pressure was applied to induce sonoporation.
Ultrasound contrast agent was added to the cell culture media (0.33% v/v) to provide
cavitation nuclei during treatment. Plasmid DNA expressing green fluorescent protein
(GFP) was added to the cell culture (250 µg/10 mL) to quantify successful permeabi-
lization. While there were no significant effects due to the temperature of the media,
transfection was successfully performed using the prototype device given the positive ex-
pression of GFP in the cells 24 hours following treatment. The mean(±s.d.) transfection
efficiencies of the sonoporation treatment at 37°C, 39.5°C, and 42°C were 5.4(±0.92)%,
5.8(±1.3)%, and 5.3(±1.1)% respectively (n = 3 for each experimental group). Negative
control treatments had transfection rates of < 1.5% on average and the detected lev-
els of apoptosis among surviving cells was < 0.5% on average for all treatment groups.
These results were in good agreement with those obtained using a different sonoporation
experimental set-up on the same cell line with similar experimental parameters.
Finally, the design of high-power ultrasound driving circuitry was explored in order
to create an electrical device with the ability to provide independent, concurrent, and
controlled excitation of the six transducers. A class DE half-bridge amplifier topology
was chosen as the output power stage of this device. A design of a class DE amplifier was
simulated using LTSpice with both a resistive 50 Ω load and a Butterworth-Van Dyke
equivalent circuit model of one of the six transducers, matched to 50 Ω at 1 MHz. The
amplifier was designed to deliver 150 W to a 50 Ω resistive load at an output frequency
of 1 MHz using a DC supply voltage of 96 V. The simulation of the amplifier using
the transducer equivalent circuit yielded an output power of 134 W, a drain efficiency
of 98.8%, a power-added efficiency of 89.0%, a gate power gain of 22.6 dB, and a total
harmonic distortion at the output of 27.9%.
The device presented here was shown to be effective at performing sonoporation on ad-
herent monolayer cell cultures and will reduce the time and expertise required to perform
this technique in the future.
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Ultrasound is a mechanical wave which can easily propagate through soft tissue in the
human body. At high intensities, thermal and non-thermal effects of the ultrasound me-
chanics become more apparent. Ultrasound waves can easily be focused to allow highly
localized effects to be produced. The biological effects of focused ultrasound were de-
scribed as early as [1] in 1942. In 1954, [2] developed a device which employed focused
ultrasound to perform thermal ablation in brain tissue. At the time, however, there was
no practical way to monitor the process. In recent decades, with the advent of magnetic
resonance imaging (MRI) and MRI thermometry, real-time monitoring of non-invasive
ultrasound has become possible [3–5]. Consequently, ultrasound has since gained a lot of
interest as a non-invasive therapeutic tool.
Focusing ultrasound energy has many potential therapeutic applications in the body.
For instance, tissue can be selectively heated using focused ultrasound in either a non-
destructive manner (e.g. mild hyperthermia) [6–8] or a resectional manner (e.g. thermal
ablation) [1–3, 5]. Non-invasive destruction of tumors, for example, is possible with high
intensity focused ultrasound (HIFU), allowing one to destroy the tumour while potentially
sparing sensitive surrounding tissue [3].
Thermal effects of ultrasound have also been used to aid in targeted drug delivery
[6–8]. Thermosensitive liposomes, for example, have been used to encapsulate therapeutic
agents in an biologically-inert lipid shell [9,10]. This shell can be disrupted non-invasively
using focused ultrasound by increasing the temperature of the shell beyond its gel-to-
liquid phase transition temperature in the desired treatment region thereby releasing the
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encapsulated therapeutic agent locally. This targeted release of the drug can potentially
spare other parts of the body from the drug’s effects [10].
Non-thermal effects of ultrasound, such as acoustic cavitation, have therapeutic ap-
plications as well. Ultrasound has been used to temporarily increase the permeability of
biological barriers to otherwise impermeable compounds [6, 11–13]. In [13], ultrasound
was used to enhance the permeability of the blood-brain barrier of rabbits in a local-
ized and transient manner. The blood-brain barrier is impermeable to many therapeutic
drugs, making the brain a difficult organ to treat [13]. With this technique, the effi-
cacy of therapeutic drugs targeting the brain can potentially be increased, requiring less
drug to be present in the bloodstream, thereby sparing other parts of the body from
undesired effects. A similar phenomenon is thought to increase the permeability of cell
membranes as well, a process which has been demonstrated both in vitro [11, 12, 14–22]
and in vivo [6–8, 23]. Cellular uptake of large genetic molecules such as small interfering
RNA (siRNA) [14, 16] and plasmid DNA (pDNA) [15, 20–22, 24, 25] has been shown to
be enhanced by the presence of micron-sized stabilized gas bodies in an ultrasonic field.
This ultrasound-induced permeability of cell membranes has been shown to be transient
in nature, with the permeability of the cell membrane returning to normal after a short
period of time [17, 19]. Delivery of genetic material into cells using ultrasound has the
potential for use in cancer therapy as these kinds of materials can disrupt actors and
processes responsible for cellular immortalization and proliferation [14, 21]. This process
provides a non-cytotoxic alternative for large molecule delivery in vivo [21].
Inducing transient increases in the permeability of cell membranes for material trans-
fer is the subject of this work. Here, a prototype device for performing large molecule
delivery in vitro on adherent cell cultures using ultrasound is presented. In vitro stud-
ies are a necessary step in developing non-invasive, targeted therapies which exploit this
phenomenon. This work presents a device which aims to reduce the time and expertise
required to perform these types of studies.
The subsequent sections in this chapter present additional background on this phe-
nomenon including a review of the potential physical mechanisms involved, measures of
its efficacy, a review of experimental parameters and their effect on its efficacy in the
literature, and a review of in vitro experimental set-ups used in the literature. Chap-
ter 2 introduces the problem statement, proposes a solution, and describes the design
and construction of a prototype for performing sonoporation in vitro; Chapter 3 details
the experimental validation of the prototype; Chapter 4 explores high-power ultrasound
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driving electronics to be used with the prototype; and Chapter 5 discusses future work.
1.2 Sonoporation
1.2.1 Physical Mechanisms
The process of inducing a transient increase in the permeability in biological membranes
using ultrasound is referred to as “sonoporation”. Ultrasound-induced membrane perme-
ability is a phenomenon attributed to the interaction between the cavitation of gas bodies
and nearby cell membranes [6,11,12]. Permeability has been shown to be enhanced by the
addition of micron-sized stabilized gas bodies (“microbubbles”) which lower the energy re-
quirements for acoustic cavitation [12,15,25]. Commercially available ultrasound contrast
agents (UCAs), which have historically been used to enhance contrast of blood vessels
in ultrasound imaging, are commonly used as sources of cavitation nuclei for enhancing
sonoporation [12,15].
Cavitating microbubbles present a number of possible modes of interaction with nearby
cell membranes which can result in pore formation [26]. At low acoustic intensities, stable
cavitation (oscillation) is thought to induce shear stress on the cell membrane through the
generation of rapid flow in the surrounding medium, referred to as “microstreaming” [27–
29] (Fig. 1.1a). In [27], the authors captured high-speed images of oscillating microbubbles
pushing and pulling on the cell membrane when in close proximity, an interaction which
correlated with increased uptake of propidium iodide. At higher acoustic intensities,
inertial cavitation (collapse) can occur, causing streams (“microjets”) to form due to the
presence of the relatively rigid cell membrane [30,31].
These microbubble-induced stresses are thought to cause physical disruptions in the
cell membrane (“pores”) which can then allow impermeable compounds to passively dif-
fuse across the cell membrane [27, 32]. There is evidence, however, that pore formation
may only facilitate cellular uptake of relatively small agents and that cavitation (or pore
formation) may be stimulating endocytosis for uptake of larger agents. In [32], the authors
observed a significant decrease in uptake of larger dextrans (70 kDa to 500 kDa) after
inhibiting endocytosis pathways, whereas smaller dextrans were still detectable. They
also observed smaller dextrans having a rather homogeneous distribution within the cell
whereas larger dextrans were heterogeneously distributed and encapsulated by “vesicle-
like structures” consistent with endocytosis.
In addition to the delivery of agents present in the extracellular region through pas-
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continuous wave (C.W.) or pulsed excitation, where pulsed modes are specified by duty
cycle (or pulse length) and pulse repetition frequency (PRF). Sonoporation is typically
performed using ultrasound frequencies ranging from a few hundred kHz to a few MHz
and pressures ranging from a few hundred kPa to a few MPa. Pulsed excitation has been
performed with duty cycles ranging from a few percent to a couple tens of percent and
PRFs of a few tens of Hz to a few kHz. A summary of acoustic conditions in a selection
of in vitro studies is available in Table 1.1.
In examining the effect of acoustic parameters on permeability and cell viability,
these acoustic parameters are often examined in the context of microbubble activity
[11, 12, 15, 18]. It has been noted that there exists an acoustic threshold below which
permeabilization and cell death do not occur, dependent on pressure, frequency and pulse
repetition frequency [11,15,18,35]. This threshold has been associated with inertial cavi-
tation [11,35] as the pressure required to surpass this threshold has been seen to increase
with frequency [11, 35]. In [15], low pressure amplitudes were unable to induce perme-
abilization, even at long pulse durations. Beyond this threshold, microbubble disruption
(i.e., inertial cavitation) is believed to occur within only a few cycles [12, 15], hence,
longer pulse durations and insonation times are considered to contribute less of an effect
to permeabilization [15, 16]. In [18], nearly all (99%) of the microbubbles were disrupted
when exceeding this threshold. However, as the authors point out, microbubble disrup-
tion may not be a sufficient indicator of successful permeabilization [18]. Permeabilization
due to microbubble concentration has been seen to plateau at low concentrations (e.g.
2%) [11,15,16]. Increasing microbubble concentration further has been seen to only lower
cell viability [15, 16,25].
Permeabilization and cell death have been noted to be inter-dependent [11,15,18,25].
That is, parameters which increase permeabilization tend to increase cell death as well.
For instance, cell permeabilization tends to increase with decreasing acoustic frequency, as
does the rate of cell death [18]. Longer pulse durations tend to increase cell permeability
but also decrease viability [18]. Increasing acoustic pressure has also been observed to
have a negative impact on cell viability while increasing permeability [11, 15, 18]. In
[18], the authors recommended that, for applications where cell survival is important,
sonoporation should be performed at high frequency, low pressure, and low duty cycle;
and in applications where viability is not important, permeabilization may be improved
by using low frequency, high pressure, and high duty cycle.





















p− Center Freq. Duty PRF Insonation
Ref. (MPa) (MHz) (%) (kHz) time (s) Notes
[11] 0.05-0.8 2.25 C.W. - n.s.
[35] 0.025∼0.4 1.0 - 7.15 C.W. - 60
[16] 0 - 4 (W cm-2) 1.706 C.W. - 15 - 120 Reported “acoustic power”
[36] 0.2 - 0.6 2.25 C.W. - 60
[29] 0.05 - 0.3 1.0 C.W. - 20
0.1 1.0 C.W. - 0 - 60
[14] 0 - 11 (W) 1.653 C.W. - 10 Reported “acoustic power”
0 - 11 (W) 1.653 10 0.002 100 Reported “acoustic power”
[12] 0.23∼0.9 3.5 2.2 1.08 - 14.8 4 - 960 Doppler mode
0.39∼1.9 3.5 0.0032 3.4 60 2D imaging mode
[37] 0.25 - 3 (W cm-2) 1.0 20 0.1 0-60 Reported Isppa
[24] 0.402 1.15 20 0.1 10
0.570 2.25 20 0.1 10
[15] 0.13 - 0.5 1.0 10 - 80 (cycles) 1.0 40 Examined pulse length
0.5 1.0 40 (cycles) 0.5 - 2.5 40 Fixed pulse length
[18] 0 - 0.57 0.5 9.6 3.0 120
0 - 2.32 2.0 9.6 3.0 120
0 - 3.5 5.0 9.6 3.0 120
0.125 - 0.57 0.5 1.2 - 9.6 3.0 120
0.125 - 0.57 0.5 16 (cycles) 0.01 - 3 120 Fixed pulse length
0.125 - 0.57 0.5 9.6 3 0 - 120
[25] 0.13 - 0.48 1.0 25 0.1 180 (∼35/cell) Transducer translated across
cell culture during exposure
[20] 0 - 1 0.930 4.8 1.5 30
[21] 1.0 0.930 4.8 1.5 30
[22] 1.0 1.0 4.8 1.6 30
[19] 0.88 (p-p) 1.5 20 1.0 30 Reported peak-to-peak pressure (p-p)
[38] 0.88 (p-p) 1.5 20 1.0 30 Reported peak-to-peak pressure (p-p)
[39] 0.62 - 1.25 (p-p) 1.5 20 1.0 30 Reported peak-to-peak pressure (p-p)
[40] 0.88 (p-p) 1.5 20 1.0 30 Reported peak-to-peak pressure (p-p)
[41] 1.2 MI 1.3 n.s. n.s. 30-60 Reported mechanical index (MI)
n.s. - not specified
Table 1.1: A summary of a selection of in vitro sonoporation experiments and their acoustic parameters.
1.2. SONOPORATION 7
ing wave formation has been shown to have a large effect on sonoporation efficacy [16].
The presence of standing waves in sonoporation studies can be problematic for reporting
the acoustic conditions under which sonoporation was performed as it is difficult to know
for certain what the conditions were [16]. In [16], the effects of standing wave formation
on sonoporation was explored in vitro and the authors found that the presence of standing
waves significantly increased transfection efficiency and decreased cell viability.
Other experimental parameters have been seen to have an effect on sonoporation effi-
cacy as well. For instance, treating cells in suspension or in monolayer may have different
effects. In [16], C166 endothelial cells treated in monolayer experienced higher viability
than those treated in suspension despite experiencing similar levels of permeability. While
some cells can be grown and survive in suspension, other cell types are inherently adher-
ent. It is likely the case that the viability of adherent cells may suffer during detachment
due to cellular processes such as anoikis.
Sonoporation efficacy tends to also be dependent on cell line [22, 42] and cellular
phase [22,43]. In [22], three different HPV-positive, cervical cancer-derived cell lines were
examined and it was observed that the average permeabilization of CaSki cells was signif-
icantly lower than that of HeLa and SiHa cells under the same experimental conditions.
Cell membrane fluidity has also been seen to contribute to transfection efficiency.
In [44], a 15-fold increase in transfection efficiency of prostate cancer PC-3 cells was
observed at cell temperatures of 42°C over temperatures of 37°C, an increase the authors
attributed to increased cell membrane fluidity due to thermal treatment. The increase
the authors observed was similar in effect to that of a lidocaine treatment, a substance
known to increase cell membrane fluidity.
1.2.4 Experimental Set-ups
The exposure of a cell culture to an acoustic field necessarily requires a cell culture and an
ultrasound source. In the literature, sonoporation has been performed using a number of
different experimental set-ups (Fig. 1.2, Table 1.2) and a number of different experimental
conditions (Table 1.1). The variety in physical conditions across the literature makes
comparing results from different studies problematic [15, 16,18,45].
Ultrasound generation is often performed using general laboratory equipment [15, 17,
18,20–22]. An electrical signal is generated by an arbitrary waveform generator, amplified
by a radio-frequency (RF) amplifier, and converted to a mechanical wave using an ultra-
sound transducer. Commercial ultrasound systems have been used in some instances to
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produce the ultrasound [12,14,16] but these systems often offer less control over acoustic
parameters [15].
There are commercially available sonoporation systems as well which aim to make
performing sonoporation studies easier. For example, the Sonidel SP100 (Sonidel Ltd.,
Dublin, Ireland) is a sonoporator which is commercially available. This device consists of
a free ultrasound transducer, driving electronics, and easy-to-use interface. While, this
device been used in a number of sonoporation studies, it often appears to be used with
“modification” [25, 46]. The acoustic conditions at the cells is not necessarily ensured
in its stock configuration due to the use of a hand-held ultrasound transducer. That
is, this sonoporator requires an additional experimental apparatus to ensure consistent
ultrasound exposure between experiments.
There are several ways in which target cell cultures can be situated in the acoustic
field. In some instances, well plates or Petri dishes were used [14, 16, 37, 41, 46]. Using
well plates or Petri dishes placed at the surface of the ultrasound bath is problematic
since acoustic reflections at the water-air interface make it difficult to know the physical
conditions under which the cells are being treated (Fig. 1.2c) [15,16]. In [14], the authors
go through great effort to avoid reflections and standing wave formation with well plates
by using a complicated set-up consisting of a second water tank placed above the well
plate, in the acoustic far-field (Fig. 1.2d).
The Opticell cell culture system (Nunc Thermo Scientific) has become a popular ex-
posure chamber for performing sonoporation on adherent monolayer cell cultures [15,19–
22,25,38–40]. An Opticell cell culture chamber consists of two thin gas-permeable mem-
branes (one of which is treated to allow cell cultures to adhere) and two rubber ports
which allow for material to be added and removed via needle and syringe. In [15], the
thin membranes of the Opticell presented <1% loss in acoustic intensity, demonstrating
that the Opticell is suitable for sonoporation applications. Opticell chambers are fully
submersible, eliminating the highly reflective liquid-air interface created when using al-
ternatives such as well-plates at the bath’s surface. Additionally, fully submersible cell
culture chambers allow for an acoustic absorber to be placed in the acoustic far-field,
mitigating reflection and standing wave formation further (Figs. 1.2e and 1.2f).
Cell cultures have been treated either as a suspension in cell culture media or as an
adherent monolayer. Suspended cell cultures are thought to reflect in vivo conditions
more accurately [16]. Suspended cells are often sonoporated in a test tube which may
be mechanically stirred or rotated (Figs. 1.2a and 1.2b) [11, 17, 24, 35, 36, 45]. Stirring or
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rotating the test tube is thought to provide the cell culture with a homogeneous ultrasound
exposure [45], however, in [35], no significant improvement in transfection efficiency was
observed using a rotating tube.
Adherent cell cultures in monolayer tend to receive multiple isolated sonoporation
treatments across their area [19–22, 25, 39, 40]. An Opticell chamber, for example, has
an area of 50 cm2. In order to perform multiple treatments with a single transducer,
a positioning system is often employed [19–22, 25, 39, 40]. For accurate reporting of the
acoustic conditions at the cells, the cell culture needs to be perfectly aligned with the
positioning system or the positioning system needs to be pre-configured (in the case of a
computerized positioning system) to correct for misalignment.
A summary of experimental set-ups for a selection of in vitro sonoporation studies is















Suspension/ Stirred/ Standing Wave
Ref. Monolayer Rotated Chamber Orientation Positioning Mitigation US Generation
[29] Suspension Test tube Bottom-up Fixed Rubber stopper General
[11] Suspension Rotating Test tube Horizontal Fixed n.s. n.s.
[35] Suspension Rotating Test tube Horizontal Fixed n.s. n.s.
[24] Suspension Rotating Test tube Horizontal Fixed n.s. n.s.
[36] Suspension Rotating Test tube Horizontal Fixed n.s. n.s.
[18] Suspension Stirred Custom Horizontal Motorized No mitigation General
[14] Suspension Well plate Bottom-up Manual Absorber US driver
[16] Both Well plate Bottom-up Manual (Under study) US driver
[37] Monolayer - Well plate Bottom-up n.s. Moving source US machine
[41] Monolayer - Well plate Bottom-up n.s. No mitigation US machine
[12] Monolayer - Custom Bottom-up Fixed n.s. Imaging system
[31] Monolayer - Petri dish Bottom/Angled Fixed Angled n.s.
[19] Monolayer - Opticell Top-down n.s. n.s. n.s.
[39] Monolayer - Opticell Top-down n.s. n.s. n.s.
[40] Monolayer - Opticell Top-down n.s. n.s. n.s.
[15] Monolayer - Opticell Top-down Fixed Absorber General
[25] Monolayer - Opticell Bottom-up Manual n.s. Sonoporation system
[38] Monolayer - Opticell Bottom-up n.s. n.s. General
[20] Monolayer - Opticell Bottom-up Motorized Absorber General
[21] Monolayer - Opticell Bottom-up Motorized Absorber General
[22] Monolayer - Opticell Bottom-up Motorized Absorber General
n.s. - not specified





2.1.1 Previous Sonoporation System
At the Thunder Bay Regional Research Institute (TBRRI), sonoporation experiments
have been performed using general-purpose laboratory equipment. The experimental
set-up for these experiments used a 3-axis, computer-controlled micropositioning system
(UMS2; Precision Acoustics, Dorsetshire, UK) to move a single-element focused ultra-
sound transducer to various positions across the area of an Opticell cell culture chamber
(Fig. 2.1). Electrical generation was performed using general lab equipment including
waveform generators and radio-frequency (RF) amplifiers. While this system has been
used to perform sonoporation in a number of studies at the TBRRI [20–22], it has a
number of drawbacks which impedes its routine use.
First, the water bath takes a considerable amount of time to set-up, treat, and tear-
down due to its size. The water tank measures approximately 97× 46× 46 cm internally,
requiring approximately 160 L of water per experiment day. A large part of the day is
spent filling the tank with deionized water, degassing the water, heating the water to a
biologically relevant temperature (e.g. 37°C), and emptying the tank. Typical times were
4 to 6 hours to set-up and about 30 minutes to tear-down.
Second, setting up the ultrasound exposure conditions is difficult without proper train-
ing and experience. The position and orientation of the cell culture needs to be determined
with respect to the 3-axis micropositioning system on a day-to-day basis before experi-
ments in order to ensure the ultrasound exposure is performed consistently at different















Figure 2.1: The previous sonoporation experimental set-up which used a large water bath
(∼160 L), a single-element focused transducer, a micropositioning system, an Opticell
chamber, an immersion heater, a circulating heater, and a circulating degasser.
target locations across the cell culture. This involves first levelling the cell culture mount-
ing apparatus and then localizing three holes on the apparatus, quasi-manually (i.e., with
the aid of software), using pulse-echo and scanning techniques.
Third, sonicating the cell culture takes considerable time as well due to the system
design. The system uses one single-element focused ultrasound transducer to perform
multiple acoustic exposures across the target cell culture. The process of sonicating each
target is automated using custom MATLAB software which controls the micropositioning
system and waveform generator. Due to the need to move and treat each zone sequentially,
the total treatment time was on the order of 25 minutes per cell culture.
Many of these issues stem from the use of general-purpose equipment to perform a spe-
cific task. A person wishing to use or build such a system must have sufficient knowledge
in each of the system’s constituent components (e.g. knowledge in software engineering,
electrical engineering, and acoustics) or the aid of people who do. Fortunately, these
issues can be addressed by designing a device for the specific application, minimizing the
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required technical expertise of the operator.
2.1.2 Proposed System
In this work, a sonoporation system is proposed which aims to reduce the time and
expertise required to perform sonoporation on cell cultures in adherent monolayer. The
design consists of an array of ultrasound transducers (i.e., multiple independent acoustic








Figure 2.2: The proposed sonoporation experimental set-up with a much smaller bath
(∼20 L), multiple fixed transducers, and simpler heating system.
The features of the proposed design address all of the issues with the previous sys-
tem. First, the compact size of the device reduces the required size of the ultrasound
bath which in-turn reduces the required bath set-up, treatment, and tear-down times.
Second, the distances between the transducers and the cell culture are set once and do
not change between experiment days, reducing the time and complexity of the set-up of
the exposure conditions. Lastly, multiple transducers can insonate multiple areas of the
cell culture either concurrently, reducing the treatment time to that of a single exposure
(e.g. 30 seconds), or sequentially, eliminating the movement times associated with the use
of a micropositioning system. The design, construction, and calibration of the proposed
system are outlined in the following sections of this chapter.







Figure 2.3: A rendering of the device (exploded) showing its transducer array, transducer
frame, body, Opticell stage, and Opticell.
2.2 Transducer Design
The general construction of the type of transducer used here is shown in Fig. 2.4. This
transducer consists of a piezoelectric element (responsible for converting energy between
electrical and mechanical forms) positioned between two other material layers: a matching
(front) material and a backing material. The front matching material is used to match
the acoustic impedance of the piezoelectric material to the acoustic impedance of the
surrounding medium (e.g. the ultrasound bath water) [47, 48]. The backing material is
used to aid in the physical damping of the piezoelectric element as well as to reflect (or
absorb) acoustic energy [47, 48]. A housing is used to hold together the piezoelectric
element, the backing and matching materials, and the electrical circuitry.
The acoustic parameters chosen for the design of the proposed system were adopted
from those used with the previous system in a number of sonoporation studies [20–22]:
0.7 MPa peak-negative pressure, 1 MHz, 4.8% duty cycle, 1.6 kHz pulse repetition fre-
quency. These parameters were chosen in order to compare the effectiveness of the pro-
posed system with the previous system.





Figure 2.4: A rendering of a transducer (exploded) showing its housing (cut-away), its
backing layer (dotted outline), its piezoelectric element, and its matching layer (dotted
outline).
The design of the transducers began with the choice of the piezoelectric elements. In
order to reduce the complexity of the device while providing a large exposure area, a large
number of small transducers was desired. After consultation with the manufacturer, the
suggested piezoelectric elements which would fulfill the design requirements were 20 mm
(nominally) in diameter (DL-47; DelPiezo Specialties LLC, West Palm Beach, FL, USA).
The dimensions of the Opticell allowed for an array of six (3×2) of these piezoelectric
elements to fit comfortably within the cell culture area (Fig. 2.5).
The transducers were designed to be air-backed. Air has a much lower acoustic
impedance than the piezoelectric crystal material (∼410 Rayl v. ∼26 MRayl). There-
fore, this backing layer will be highly reflective of acoustic energy being transmitted out
of the back of the crystal [47]. The water in front of the transducer has an acoustic
impedance much closer to the crystal material than air, though still an order of magni-
tude less (∼1.5 MRayl v. ∼26 MRayl). Although the maximum transfer of energy occurs
when acoustic impedances are equal, no front material was used to match the acoustic
impedance between the crystal and the water bath.
Important physical features of the transducer housing are shown in Fig. 2.6. The
transducer housing has openings at both ends. The wide opening at the top of the housing
is designed to accept a circular piezoelectric element and a small “lip” was designed into
this opening for the piezoelectric element to rest (Fig. 2.6:2). The opening widens near
the top of the housing to allow for epoxy (EPO-TEK 301; Epoxy Technology, Billerica,
MA, USA) to be set between the housing and the piezoelectric element (Fig. 2.6:1). This
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Figure 2.5: An orthographic projection showing the placement of the six transducer ele-
ments with respect the Opticell cell culture area.
epoxy both holds the piezoelectric element in place and provides waterproofing for the
transducer air-backing. The opening at the bottom of the housing allows for the electrical
signal cable to be inserted (Fig. 2.6:4) (also sealed with epoxy). Three vertical channels
are evenly spaced around the inside of the housing which allow ground (GND) wires to
be connected from the signal cable termination inside the housing to the external face of
the piezoelectric element (Fig. 2.6:3).
2.3 Modelling and CAD
The device components were modelled using OpenSCAD (2013.02.28) [49], a tool which
provides a language-based interface for modelling 3D objects using constructive solid
geometry (CSG). Models created in OpenSCAD were exported to stereolithography format
(.stl) and prepared for printing using ReplicatorG (0037) [50] with skeinforge (50)
[51]. The 3D objects were then printed using a Makerbot Replicator desktop 3D printer
(Makerbot Industries, New York, NY, USA) using ABS plastic. ABS plastic was chosen
after a sample piece underwent a soak test and its wet mass was not largely different from
its dry mass, signifying that it did not absorb a significant amount of water.
ReplicatorG and skeinforge provide options for adjusting the density of the objects
being printed. This is done by using a solid wall for all external surfaces of the object
and using a supporting structure of lesser density, such as a honeycomb, internally. The
remainder of the internal volume of the object is occupied by air. The printed pattern












Figure 2.6: Physical features of the transducer housing design: (1) a gap between the
transducer and the housing for epoxy to be placed; (2) a small lip for the transducer to
rest on; (3) channels for ground (GND) wires to be run from the inside of the housing to
the outside; and (4) the hole for the coaxial cable. These parts can be seen (a) from the
side (cutaway), (b) from an angled perspective, and (c) from above.
for the internal structure can be adjusted for density, affecting the time and material
requirements for printing. Since it is necessary for the device presented here to be fully
submerged in a water bath, these options were adjusted to achieve maximum fill density
for every part of the device in order to minimize the internal air gaps, to minimize leaking
and absorption, and to allow for the tapping of holes for fixing screws.
2.4 Transducer Construction
The exterior of each transducer housing was treated in a shallow acetone bath for 1 to 2
seconds per side. The acetone treatment was performed to smooth and help fill the rough
exterior in order to minimize the possibility of leaking.
Coaxial cable (RG-174 type, 24.5 AWG; Belden, St. Louis, MO, USA) was used to
connect to the piezoelectric element to the driving circuitry. The end of the coaxial cable
was fed through the bottom hole before connecting to the piezoelectric element. Six
electrical connections were made between the coaxial cable and the piezoelectric element
(Fig. 2.7) using 26 ∼ 30 AWG stranded wire. Three connections to ground (GND)
were evenly spaced around the outside edge of the exterior-facing side of the crystal and
three signal connections were made on the interior-facing side of the crystal. The signal
connections were staggered evenly with respect to the positions of the ground connections






Figure 2.7: (a) Locations of solder points for the signal v(t) (circles) and ground (GND)
connections (squares). (b) A cut-away of the housing showing the internal and external
connections to the (translucent) piezoelectric element. Ground connections are made on
the outer-facing side of the element and the signal is applied to the inside-facing side of
the element.
and made half-way between the center of the element and its edge (Fig. 2.7a).






Figure 2.8: L-type (two-element) matching network where Re{ZB} > Re{ZA}.
The electrical impedance of each transducer was matched to 50 Ω at 1 MHz using an
L-type (two-element) matching network (Fig. 2.8). The goal of the matching network is
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to ensure that maximum power is transferred between ZA and ZB [52]. While the quality
factor of this type of network cannot be controlled, it is normally low [52].
L-type matching networks come in low-pass and high-pass varieties. In the low-pass L-
type matching network, the series reactance, X1, is an inductor, and the parallel reactance,
X2, is a capacitor. For the high-pass case, the opposite is true. In both cases, the parallel
reactance X2 is in parallel with the component with the larger Re{Z}. Thus, there
need not be any differentiation between which is the source and which is the load when
performing the analysis [52].
Matching is performed for a single frequency by satisfying the following equality:
Z∗A = Z1 + Z2‖ZB (2.1)







where X1 and B2 are the reactance of the series matching component and the susceptance
of the parallel matching component respectively. If X = X1 + XA then the solution to
the matching circuit can be found by equating the real and imaginary parts and solving
























Due to the compact size of the transducer housings, matching networks were installed
in small boxes placed between the 50 Ω source and the terminated end of the coaxial cable
of each transducer (Fig. 2.9). Hence, the impedance matching involved the impedance of
both the piezoelectric element and the coaxial cable.
Matching was performed with the aid of an RF network analyser (8127ES; Hewlett
Packard, Palo Alto, CA, USA) calibrated to using a 85032E Type N calibration kit
(Hewlett Packard, Palo Alto, CA, USA). The matching network was manually tuned
from initial values by adjusting the inductance by the number of turns on the inductor
and the capacitance by adding or removing parallel capacitors with the aid of a Smith
chart [52]. The results of the matching procedure are listed in Table 2.1.








Figure 2.9: (a) The inside of a matching box with two L-type low-pass matching circuits
and external male BNC connectors featuring hand-wound iron-powder-core (Material #1;
Amidon Inc., Costa Mesa, CA, USA) toroid inductors and high-voltage ceramic capac-
itors. (b) A schematic showing the matching circuit in place. The matching network
input calibrated to 50 Ω and the load impedance includes both line and piezo-element
impedances. While the matching network shown assumes Re{Zline + Zpiezo} < 50 Ω, this
may not be true, in which case X2 would be in parallel with Zline + Zpiezo instead.
Device Unmatched Z (Ω) L (µH) C (nF) Matched Z (Ω) Matched |Γ|
A 45.78 + j7.028 1.09 0.966 50.85 + j1.402 0.01626
B 50.76− j8.435 1.65 0.127 50.98 + j2.029 0.02231
C 30.36− j6.428 4.91 2.56 48.21− j1.603 0.02446
D 44.13− j4.374 3.26 1.16 50.15− j0.739 0.007529
E 47.34− j8.224 3.09 0.755 48.57− j1.585 0.02165
F 46.97− j2.415 2.28 0.808 52.71− j0.439 0.02673
Table 2.1: The unmatched and matched impedances (Z = R + jX) at 1 MHz for each
transducer, the (theoretical) component values to match to 50 Ω at 1 MHz, and the
reflection coefficient magnitude |Γ| after matching.





















Figure 2.10: Hydrophone scanning acquisition set-up. The output of a waveform generator
(1 MHz, 30 cycles, 10 Hz PRF) is first amplified by an RF power amplifier. The electrical
output power is measured using a directional coupler and power meter. The amplified
signal is sent to the matching circuit and transducer. The acoustic pressure generated by
the transducer is converted to a voltage using a hydrophone. The hydrophone is attached
to the arm of a 3-axis micropositioning system. The hydrophone signal is (optionally)
boosted by a booster amplifier before being captured by an oscilloscope. A PC reads the
captured hydrophone voltage waveform from the oscilloscope for processing.
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2.6 Transducer Field Characterization
2.6.1 Acquisition Set-up
Hydrophone scanning was employed to obtain a detailed map of the acoustic profile of
each transducer. Measurements were conducted using a previously calibrated needle hy-
drophone using a 0.2 mm tip (SN1426; Precision Acoustics, Dorsetshire, UK). An ul-
trasound pulse was generated using an arbitrary waveform generator (33522; Agilent
Technologies Canada Inc., Mississauga, ON, Canada) and amplified using a linear RF
amplifier (A250; E&I, Rochester, NY, USA). This pulse was defined as a 1 MHz pulse
of 30 cycles, generated every 100 ms (10 Hz). The hydrophone was placed at various
positions within the acoustic beam of the transducer under test using a 3-axis motorized
micropositioning system (UMS2; Precision Acoustics, Dorsetshire, UK). Automatic posi-
tioning and waveform acquisition was performed using a custom MATLAB programme. A
schematic for the acquisition setup is shown in Fig. 2.10.
The acoustic field was reconstructed automatically using a custom MATLAB programme.
At each point the hydrophone visited, the software obtained the hydrophone voltage wave-
form and computed its root-mean-square (RMS) value. The RMS value was calculated
from the beginning of the pulsed waveform to the end of the pulsed waveform, which may
be offset in time from the moment of excitation based on the distance of the hydrophone
from the transducer and the speed of sound of the water bath. The acoustic field pulse-
average intensity (Isppa) for the given point in space will be proportional to the square of









where c and ρ are the speeds of sound and density of the propagation medium, and prms
is the pulse-averaged pressure which is proporational to the calculated RMS hydrophone
voltage by the linear response of the hydrophone M(f) at operating frequency f [53].
The custom MATLAB acquisition programme is only capable of performing scans along
the axes of the positioning system. This limitation required the transducer beam axis
to be physically aligned with one of the three micropositioning system axes. Additional
recommendations for performing hydrophone measurements, including alignment, were
available from the manufacturer [53].
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Figure 2.11: Normalized intensity along the acoustic axis for an ideal disc source 20 mm
in diameter, operating at 1 MHz in water (c = 1500 m/s).
2.6.2 Optimal Treatment Plane
Unlike curved (focused) transducers, planar transducers do not have a geometric focus.
However, they do have what is considered a “natural focus”, a distance where the acoustic
field transitions from the near- to the far-field (znf ) [48]. The acoustic field in the near-
field (z < znf ) is highly heterogeneous due to the constructive and destructive interference
of waves contributed by different points on the transducer’s surface. At a given point near
the source, the distance between each point on the surface of the source and this point
in space varies greatly across the surface, leading to large changes in phase contributions.
However, in the far-field (z > znf ), the distances between points on the surface of the
transducer and a given point in space become more similar and the acoustic field becomes
more homogeneous.
The normalized intensity I/Ipeak along the propagation axis for an ideal disc source is
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(2.6)
where a is the radius of the disc source, λ is the wave length of the medium, and z is
the distance along the propagation axis [48]. The distance at which the near-far field





where a is the radius of the disc source and λ is the wave length of the medium [48]. At
this distance, the intensity along the propagation axis, given by (2.6), peaks for a final
time before decaying [48].
The solution to (2.6) for a disc source 20 mm in diameter, operating at 1 MHz in
water (c = 1500 m/s) is plotted in Fig. 2.11. For this source the near-far field transition
distance is approximately 66.3 mm.
In order to develop a compact device, it may be necessary to work within the near-field
region. In [15], sonoporation is performed in the near-field with minimal spacing between
the transducer and cell culture as the authors consider the treatment plane homogeneous
at this distance. It is possible, however, to find an optimal treatment plane in the near-
field which exhibits a resonable level of homogeneity.
To determine the optimal near-field treatment plane, planar scans of the acoustic field
were performed in the near-field region. The planes were 10.5×10.5 mm in size at a
resolution of 0.7 mm (< 1/2λ). These planes were obtained between 10 mm and 20 mm
from the transducer surface. This range was chosen as it encompasses the region between
the last two intensity peaks before znf (Fig. 2.11).
A circular region, 10.5 mm in diameter, was sampled to encompass the symmetry of
the field while computing the homogeneity of the field on the plane (Fig. 2.12b). The
homogeneity was quantified as the standard deviation from the mean intensity within
this circular region. The optimal plane was the plane where the standard deviation was
minimum (i.e., minimum variation in acoustic intensity from the mean) and the axial
distance at which this plane occurred became the “optimal treatment distance” (Fig.
2.13). The optimal treatment distance for each transducer is summarized in Table 2.2.

























Figure 2.12: (a) A planar acquisition (∆x = ∆y = 0.7 mm) showing relative acoustic
intensity at z=16 mm; (b) A binary mask used to sample acoustic field intensity (where
black) for homogeneity.
2.6.3 Electrical Power Required to Produce Peak Pressure
Once the optimal plane was identified for a given transducer, the electrical power required
to produce the desired acoustic pressure (i.e., 0.7 MPa peak-negative) on this plane was
determined. The booster amplifier was removed and the hydrophone signal was measured
directly by the oscilloscope. A dual-directional coupler (C5685-10; Werlatone Inc.) and
power meter (2× N8482H sensors and N1914A meter; Agilent Technologies Canada Inc.,
Mississauga, ON, Canada) were used to measure the total forward electrical power. The
hydrophone was positioned at a point on the optimal treatment plane which had ap-
proximately 90% of the peak intensity and the waveform generator’s output voltage was
slowly adjusted up from 0 mVpp until the oscilloscope measured the desired peak-negative
voltage. This peak voltage was determined by the hydrophone’s linear sensitivity, M(f),





where p(r, t) and V (r, t) are the pressure and corresponding hydrophone voltage at spatial
point r and time t [53]. The results of the acoustic field characterizations are summarized
in Table 2.2.
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Figure 2.13: The heterogeneity (s.d.) of the acoustic intensity over a centered, circular
region on each plane along the acoustic axis of a transducer. The minimum relative
heterogeneity is seen at z = 16mm represents the most homogeneous plane. This distance
(z = 16mm) is chosen as the optimal treatment distance for the transducer.
2.6.4 Cross-talk
Each transducer in the array is approximately 6 mm apart at their closest point. In order
to determine the risk of cross-talk between adjacent transducers, the acoustic field for one
of the transducers was acquired over a wider plane, 40×40 mm in size, at the transducer’s
treatment distance (Fig. 2.14). The widths where the relative acoustic intensity is -3 dB,
-6 dB and -12 dB are approximately 2.18 mm, 10.5 mm, and 18.9 mm respectively. Peaks
of approximately -18 dB appear in adjacent zones.
2.7 Transducer Array Configuration
The final step in the construction of the sonoporation platform was configuring the trans-
ducer array. The transducer positions were adjusted such that the distance between the
each transducer face and the target Opticell membrane were as close as possible to the
optimal treatment distances obtained from the acoustic characterization.
In order to accurately measure the distance between a transducer and the Opticell
membrane, a secondary (imaging) transducer was used to generate a pulse and measure
the resultant echoes (Fig. 2.15). One of the two membranes of a dummy Opticell was
removed to prevent its unwanted echo. The transducer array was fixed and levelled in the
ultrasound bath and the imaging transducer was aimed at the transducer being adjusted.























Figure 2.14: The planar acoustic profile of a transducer over a wide area at its optimal
treatment distance. Orthographic projections of 20 mm circular transducers are overlaid
(black, thick-dashed) to represent adjacent zones. Peaks of approximately -18 dB appear
in neighbouring zones.
The echo from the Opticell membrane arrived first at time t1 and the echo from the
transducer surface arrived second at time t2. The difference in time between the echoes is
directly proportional (by the speed of sound in the bath) to the relative distance between





where ∆d is the relative distance between the transducer face and Opticell membrane, ∆t
is the difference in time between the echoes, and c is the speed of sound in the propagation
medium (i.e., water).
The transducer array was held in place with five set screws, one for each “row” and
“column” of the array. The transducers were held in each row and column by frictional
force produced by the set screw position. A single transducer was able to be adjusted (or















Figure 2.15: Setting the distances between the transducers and the Opticell membrane.
A short pulse (1) is sent from an imaging transducer. After time t1, the echo from the
Opticell membrane (2) returns to the imaging transducer. Shortly after, at time t2, the
echo from the transducer face (3) returns to the imaging transducer. The transducer
distance can be adjusted such that the time between echoes corresponds to the optimal
treatment distance.
later replaced) by loosening both set screws for the row and column it belongs to. The
other transducers in the same row remained in place by the force of the set screw in their
columns and the other transducers in the same column remained in place by the force
of the set screw in its row. When a transducer was adjusted to the desired position, the
set screws for its row and column were tightened, fixing it in place. Once the transducer
distances were set, the platform was ready for use (Fig. 2.16).
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Device Treatment -3 dB width Nominal source amplitude Electrical power
distance (mm) (mm) (mVpp) for 0.7 MPa (W)
A 17.0 2.33 410 106
B 16.0 2.18 380 94
C 14.7 1.68 370 94
D 16.0 1.78 360 85
E 15.8 1.96 430 123
F 15.9 1.89 390 106
Mean(±s.d.) 15.9(±0.67) 1.97(±0.22) 390(±23.8) 101(±12.2)
Table 2.2: Summary of transducer characterization





A sonoporation study was carried out using the prototype sonoporation platform. The
purpose of this study was two-fold. First, the study aimed to examine the effect of cell
temperature on sonoporation efficacy. Second, the study allowed for the design of the
device to be experimentally validated.
Pore formation during sonoporation is mainly attributed to non-thermal mechanisms.
There is evidence, however, that both cell membranes and microbubbles — two non-
thermal actors associated with pore formation — have temperature-dependent qualities
including cell membrane fluidity [44, 54] and microbubble population size [55–57] which
may affect transfection efficiency and cell viability. In [44], increasing the temperature of
the cells to 42°C gave a 15-fold improvement of transfection efficiency of prostate cancer
PC-3 cells over the same treatment at 37°C.
Sonoporation is of particular interest to those in the field of cancer research as it
promises to provide a non-viral means for targeted drug delivery and gene therapy. High-
risk human papillomavirus (HPV) infection is strongly associated with the development
of cervical cancer, the second most common cancer affecting women world-wide [58]. Cur-
rently, standard treatment of cervical cancer includes radiation therapy and surgery, each
having their own undesirable side-effects. Ultrasound-mediated delivery of therapeutic
macromolecules which target the oncoproteins encoded by the HPV DNA (e.g. plas-
mid DNA [15, 24] and small interfering RNA [14, 21]) may provide a minimally-invasive
alternative to current treatment options.











Figure 3.1: Sonoporation set-up featuring a transducer array below an Opticell chamber.
Beyond the cell culture is an ultrasound-absorbent material (Aptiflex; Precision Acoustics,
Dorsetshire, UK) intended to reduce reflection and standing wave formation.
3.2 Materials and Methods
3.2.1 Experimental Groups
Experiments were divided into nine groups consisting of three different treatments and
three different temperatures. Cells either underwent a sonoporation treatment (US+UCA)
which exposed the cells to high-intensity ultrasound with UCA present, an ultrasound
treatment (US) which exposed the cells to high-intensity ultrasound without UCA present,
or a sham ultrasound treatment (UCA) which used zero acoustic power (amplifier turned
off) with UCA present. Each of these three treatments was performed at 37°C, 39.5°C,
and 42°C with plasmid DNA present. All nine experimental groups were repeated three
times.
3.2.2 Ultrasound Exposure
The ultrasound generation parameters used in the experimental validation were adopted
from previous studies by our group [21, 22] in order to compare its relative performance
with our previous system. These parameters were originally chosen based on preliminary
work by our own group [20]. Pulsed ultrasound at 1 MHz delivered at a peak-negative
pressure of 0.7 MPa to the cell culture in bursts of 30 cycles every 625 µs (4.8% duty
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cycle; 1.6 kHz pulse repetition frequency) for a total time of 30 seconds.
The ultrasound signal for performing both characterization and sonoporation was gen-
erated using a waveform generator (33522; Agilent Technologies Canada Inc., Missis-
sauga, ON, Canada) and amplified using a linear, radio-frequency power amplifier (A150;
E&I, Rochester, NY, USA). The power during sonication was monitored using an in-line
directional coupler (C5685-10; Werlatone Inc., Patterson, NY, USA) and power meter
(2ÖN8482H sensors and N1914A meter; Agilent Technologies Canada Inc.) This setup
allowed for the excitation of one transducer at a time during experiments. Hence, each
treatment area of the cell culture chamber was treated sequentially in random order. An
additional period of 30 seconds after each exposure was added to allow the operator to
switch to the next transducer in the array.
3.2.3 Cell Culture and Plasmid DNA
Cervical cancer-derived SiHa cells (ATCC HTB-35, Manassas, VA, USA) were used in
this study. Such cells contain 1-2 genome copies of HPV type 16 per cell [59]. The
cells were maintained in 75 cm2 flasks containing Dulbecco’s Modified Eagle Medium
(DMEM; Sigma-Aldrich, Oakville, ON, Canada) supplemented with 10% heat-inactivated
fetal bovine serum (FBS; Hyclone Laboratories Inc., Logan, UT, USA), 100 U of penicillin,
100 µg of streptomycin, and 0.25 µg amphotericin B per mL (antibiotic/antimycotic;
Gibco, Grand Island, NY, USA) at 37◦C and 5% CO2. The cells were passaged to maintain
70–80% confluency. Twenty-four hours before treatment, the cells were seeded (0.6Ö106)
into an Opticell chamber to allow the cells to adhere to the inside membrane.
Plasmid DNA (pDNA) expressing green fluorescent protein (GFP) was used to quan-
tify successful transfection. The GFP plasmid cannot passively cross the cell membrane,
hence, green fluorescence will only be visible in successfully permeabilized cells. To pro-
duce the plasmid, chemically competent NEB 5-αF’Iq Escherichia coli bacteria (New
England Bio Labs Inc., Ipswich, MA, USA) were transformed with 6.3-kb Omicslink
pReciverM03 plasmid containing the GFP gene (Genecopia Inc., Rockville, MD, USA).
Plasmid DNA was extracted and purified with EndoFree Plasmid Maxi Purification kits
(Qiagen Inc., Toronto, ON, Canada) to minimize bacterial endotoxin levels. Prior to
treatment, the cells were washed with serum and antibiotic-free DMEM and incubated
with 250 µg of GFP plasmid DNA in 10 mL of serum and antibiotic-free DMEM for 15
minutes at 37°C and 5% CO2.
Immediately following treatment, the Opticell was removed from the ultrasound bath,
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wiped with 70% ethanol, and returned to the incubator where the cells were incubated at
37°C. The cells were given 2 hours of incubation time to stabilize after treatment. At this
time, 1.1 mL of serum free media was removed from the Opticell and the remaining media
was supplemented with 1 mL of FBS and 100 µL of antibiotic/antimycotic, returning the
cells to their original media composition. The cells were then incubated for an additional
24 hours to allow for the development of GFP in the cells.
3.2.4 Ultrasound contrast agent
Definity ultrasound contrast agent (Lantheus Medical Imaging, North Billerica, MA,
USA), consisting of bubbles of a perflutren gas core and lipid shell, was used to intro-
duce cavitation nuclei during the sonoporation process. The contrast agent was activated
according to the manufacturer’s recommended procedures (Vialmix, Lantheus medical
Imaging, North Billerica, MA, USA). For those experimental groups which included con-
trast agent, 33 µL of activated contrast agent was added to the 10 mL media in the
Opticell chamber 1 minute before transferring to the water bath, giving a final volume
concentration of 0.33%. Nominally, activated Definity contains 1.2Ö1010 microbubbles
per mL corresponding to a microbubble-cell ratio of 660:1. However, in [18], the authors
reported that many of the microbubbles in Definity UCA are small (<1 µm) and observed
those on the range 1∼8 µm at ∼33 microbubbles per mL. This would correspond to ∼ 1.8
microbubbles per cell. During treatment, the Opticell was placed horizontally in the cell
culture stage with the cells on the upper-most membrane, allowing for the microbubbles
to rise and rest against the cells during insonation.
3.2.5 Bath Conditioning and Heat Treatment
Experiments were conducted in a bath of deionized, degassed water (Fig. 3.1). The
bath water was initially circulated through a degassing system until the detectable level
of dissolved oxygen was <1.0 ppm (407510A; Extech Instruments Corporation, Nashua,
NH, USA). The water was also circulated through an in-line water heater (Model 210;
PolyScience, Niles, IL, USA) to raise it to the desired temperature. The heater continued
to circulate water throughout the duration of the experiment in order to maintain the
temperature of the bath. The compact dimensions of the device allowed for experiments
to be performed in a small water tank (a 26 L tote) reducing the time consumed by filling
and emptying the tank as well as degassing and heating the water bath.
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Figure 3.2: An illustration of the exposure zones and imaging areas. The Opticells were
cut along the a 20 mm diameter region (dotted lines) to be treated for mounting on slides.
Imaging occurred within the center 10 mm diameter region (approx. -6 dB intensity) of
the cut-outs on slides (solid line).
The cells and medium in the Opticell chamber were given 1 minute to equalize with
the temperature of the surrounding bath before starting the ultrasound exposure. This
value was determined experimentally by measuring the time that water in an Opticell
chamber took to rise from the temperature of the incubator (37°C) to the maximum bath
temperature tested (42°C). Due to the large ratio between the surface area and the volume
of the Opticell, the average time for this rise to occur was approximately 40 seconds, which
was rounded up to 1 minute to ensure the temperature had stabilized.
Considering the initial temperature equalization time and subsequent treatment time,
each Opticell was submerged in the bath for a total of 7 minutes.
3.2.6 Quantification of Permeabilization and Viability
Permeabilization and viability were quantified using microscopy and image processing
(Fig. 3.2). Cell imaging was performed using a Zeiss Axiovert 200 inverted microscope
(Carl Zeiss Canada Ltd., North York, ON, Canada) and an LD A-Plan 10Ö/0.25 Ph1
objective for a total magnification of 100Ö. A 12-bit CCD camera (Q Imaging, Surrey,
BC, Canada) was used to capture the microscope images to digital format for processing.
Each image taken measured 1376 Ö1024 pixels, translating to an area of 2.752 Ö2.048
mm at 50 pixels per µm.





Figure 3.3: Various images used in transfection and apoptosis quantification. Images (a)
and (b) are a blue DAPI intensity image and the associated segmented nuclei objects
(white) respectively. Image (c) is a green GFP secondary antibody intensity image, (d)
are the associated segmented cell objects (white), and (e) are the positive objects detected
using (c) and (d). Image (f) is the red cleaved PARP secondary antibody image, (g) are
the associated nuclei objects (from (b)), and (h) are the positive objects detected using
(f) and (g).
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Cell loss (detachment) was evaluated by imaging the cell cultures in three random
spots per exposure area (18 total per replicate) 15 minutes before and 2 hours after
treatment with phase contrast imaging. Each cell was manually identified by applying an
identifying marker (a dot) over the digital phase contrast images and subsequently creating
a new image containing only the dots on a blank background. These marked images were
then used to automatically obtain cell counts per field of view using CellProfiler software
(2.0.0) [60]. The cell counts per field of view were averaged per replicate for analysis.
The cell loss for each replicate was evaluated as the relative change in the average cell
count 15 minutes before and 2 hours after treatment where a negative relative change
represented a drop in cell count. It was assumed that any cells that detached were non-
viable. The viability of the remaining cells was determined by visualizing cleaved Poly
(ADP-ribose) polymerase (PARP), an early apoptotic indicator, 24 hours after treatment.
Twenty-four hours following treatment, the Opticell membrane with the adhered cells
was removed and the cells were fixed with a 4% solution of paraformaldehyde (PFA) in
phosphate buffered saline (PBS). The fixed cells were permeabilized with 0.1% solution
of Triton-X in PBS for 5 minutes and rinsed with PBS. The cells were then blocked with
1% solution of bovine serum albumin (BSA) in PBS for 10 minutes at room temperature.
Since the fluorescent signal produced by the GFP was quenched by the PFA fixing, a goat
polyclonal anti-GFP antibody (ab5450; Abcam Inc., Toronto, ON, Canada) was applied
at 1:1000 in 1% BSA/PBS to bind to the GFP protein produced by transfected plasmid. A
green fluorescent AlexaFluor 488 donkey anti-goat secondary antibody (LifeTechnologies
Inc., Burlington, ON, Canada) was applied at 1:400 in 1% BSA/PBS to visualize the anti-
bodies bound to the GFP. A monoclonal mouse anti-cleaved PARP antibody (ab1103315;
Abcam Inc., Toronto, ON, Canada) was applied at 1:760 in 1% BSA/PBS and visualized
with a secondary red fluorescent Alexa Fluor 594 donkey anti-mouse antibody (LifeTech-
nologies Inc., Burlington, ON, Canada) applied at 1:800 in 1% BSA/PBS. The cells were
counter-stained with 4’,6-diamidino-2-phenylindole (DAPI) to identify the nuclei of the
cells before being mounted onto slides for imaging.
The stained cells were imaged in five random spots per treatment area using green,
blue, and red fluorescence filters. One of the six treatment areas was used as a staining
control, limiting the total available fields of view for analysis to 25 per replicate. Each
field of view was captured for each of the three stains.
Object segmentation was performed on the fluorescent microscopy images (Fig. 3.3)
using CellProfiler (2.0.0) [60]. Two types of “objects” (independent areas of the image)
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were extracted in each field of view: 1) the nuclei objects, extracted from the blue DAPI
images; and 2) cell boundary objects, extracted using a combination of the blue DAPI and
green GFP secondary antibody images. These objects were extracted using an Ostu-global
segmentation method with minimization of weighted variance. The extracted objects
represented areas of the image occupied by individual nuclei (nuclei objects) or cells (cell
boundary objects). Consequently, the background of the image was identifiable, based on
the area not occupied by any object.
For an object to be considered positive for either transfection (green) or apoptosis
(red), the image intensity inside the object should be significantly higher than the image
intensity of the background. Thus, the following criterion was used to detect positive
objects:
Īobj ≥ Ībg + nσbg (3.1)
where Īobj is the mean image intensity within an object, Ībg is the mean intensity of the
background, σbg is the standard deviation of the background intensity, and n is the number
of standard deviations that the mean object intensity must be from the mean background
intensity for the object to be considered positive. In [21], a value of n = 2 was used with
this method. This threshold was increased to n = 3 in this work. A cell was considered
transfected if it met this criterion using the green GFP secondary antibody images. Cell
boundary objects were used in transfection detection since the GFP secondary antibody
signal would be observed in both the cytoplasm and nucleus of each positive cell (Fig.
3.3c-e). This same criterion was used for detecting cells positive for apoptosis using the
intensity of the red cleaved PARP secondary antibody images. Since the cleaved PARP
secondary antibody signal would be observed in the nucleus of each positive cell, the
nuclei objects were used (Fig. 3.3f-h). The number of objects positive for transfection
and apoptosis were counted relative to the number of cells in the image. The fraction of
positive objects within each field of view was averaged per replicate for statistical analysis.
3.2.7 Statistical Analysis
Statistical analysis was performed using R (2.15.2) [61]. Observations were tested for
normality using the Shapiro-Wilk test and homogeneity of variance using Bartletts test.
A two-way ANOVA was used to test the effects on parametric data. A post-hoc Tukeys

























Figure 3.4: Transfection rates for each treatment and temperature tested. Post-hoc
analysis showed that the US+UCA treatment group had significantly higher percent-
age of transfected cells over the other two treatment groups independent of temperature
(p<0.001 for both). There was no significant effects observed in transfection rates with
temperature or treatment-temperature mixed effects. Error bars represent ±s.d. (n=3
per group)
parametric data, the Kruskal-Wallis rank sum test was used to test effects and a post-hoc
pair-wise Wilcoxon rank sum test was performed for significant effects. The significance
level (α) was made 0.05 a priori.
3.3 Results
3.3.1 Transfection Efficiency
Treatment was observed to have a significant effect on transfection efficiency (p<0.001).
Post-hoc analysis showed that the cells that received the sonoporation treatment (US+UCA)
had a significantly higher expression of GFP over the control treatments (p<0.001 for
both). Transfection efficiency was not observed to be significantly affected by bath tem-
perature (p=0.564) or treatment-temperature interaction effects (p=0.684). Transfection
rates for each experimental group are shown in Fig. 3.4. For temperatures of 37°C,
39.5°C, and 42°C the average(±s.d.) percentages of transfected cells for the sonoporation
treatment (US+UCA) were 5.4(±0.92)%, 5.8(±1.3)%, and 5.3(±1.1)% respectively; the
percentages of transfected cells for the ultrasound treatment (US) were 0.66(±0.38)%,
1.1(±0.46)%, and 0.57(±0.26)% respectively; and the percentages of transfected cells for
the sham treatment (UCA) were 0.50(±0.22)%, 0.73(±0.24)%, and 1.3(±0.53)% respec-
tively.






















Figure 3.5: Relative change in cell count following treatment (+2h) for each treatment
and temperature. Post-hoc analysis showed US+UCA treatment has significantly higher
cell loss over the other two treatments (p<0.001 for both). There was no significant effects
observed in transfection rates with temperature or treatment-temperature mixed effects.






















Figure 3.6: The ratio of apoptotic cells for each treatment and temperature. Apoptosis
rates were low (<0.75%) across all treatments and temperatures. No significant effects on
apoptosis rates were observed with treatment, temperature, or mixed-effects. Error bars
represent ±s.d. (n=3 per group)
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3.3.2 Cell Viability
Cell loss was not significantly affected by temperature (p=0.661) or treatment-temperature
mixed effects (p=0.778). However, cell loss was found to be significantly affected by treat-
ment (p<0.001). Post-hoc analysis showed that US+UCA treatment had significantly
higher levels of cell loss over the US and UCA treatment groups (p=0.0076 and p=0.0002
respectively). Rates of cell loss following treatment for each experimental group are shown
in Fig. 3.5. For temperatures of 37°C, 39.5°C, and 42°C, the cell losses for the US+UCA
treatment group were -31(±3.4)%, -32(±13)%, and -34(±17)% respectively; cell losses for
the US treatment group were -6.7(±7.9)%, -9.1(±8.3)%, and -18(±5.9)% respectively; and
cell losses for the UCA treatment group were -5.6(±7.4)%, -2.8(±7.9)%, and -2.2(±12.2)%
respectively.
The percentage of remaining cells indicating apoptosis 24 hours following treatment
was low (<0.75%) and was not significantly affected by treatment (p=0.437), tempera-
ture (p=0.896), or treatment-temperature interaction effects (p=0.371). Rates of apop-
tosis for each experimental group are shown in Fig. 3.6. For temperatures of 37°C,
39.5°C, and 42°C, the ratios of apoptotic cells for the US+UCA group were 0.34(±0.15)%,
0.22(±0.08)%, and 0.41(±0.2)% respectively; the ratios of apoptotic cells for the US group
were 0.31(±0.25)%, 0.22(±0.10)%, and 0.23(±0.11)% respectively; and the ratios of apop-




The design of the sonoporation device presented here was able to induce significantly
higher expression of GFP over the control groups 24 hours following treatment. This
device was chosen to operate under the similar excitation parameters as our previous
system in order to compare its relative performance. In [22], our previous system produced
a transfection efficiency of 6(±2)% with a cell detachment rate of -47(±32)% using similar
excitation parameters, plasmid, and cell line. At 37°C, the system presented here was able
to achieve a transfection rate of 5.4(±0.92)% with a cell detachment rate of -31(±3.4)%.
The rates seen here are slightly lower than those seen with our previous system. As
permeabilization has been noted to be dependent on the acoustic pressure [12,18], a lower
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rate of permeabilization may be due to the use of 0.7 MPa here which is lower than the
1 MPa used in [22].
To the best of our knowledge, there are no other groups performing sonoporation on
SiHa cells in particular. Furthermore, the acoustic excitation parameters, acoustic condi-
tions, and impermeable agent used vary across the literature, making comparisons between
different studies difficult. There are a number of studies on adherent cell cultures which
exhibit similar rates of transfection albeit under different acoustic and experimental con-
ditions. For example, in [15], sonoporation using 1 MHz pulsed ultrasound was examined
under a number of different excitation parameters using a near-field set-up. The authors
found that sonoporation at their optimal parameters (1 MHz, 0.25 MPa peak-negative
pressure, 4% duty cycle, 1 kHz PRF, 10 s exposure, 4% SonoVue UCA concentration)
was able to deliver plasmid DNA at a rate of ∼4% to Chinese hamster ovary (CHO) cells
with ∼90% cell viability.
3.4.2 Cell detachment
The presence of UCA during ultrasound exposure not only had a significant effect on
permeability but it also appeared to have a significant effect on cell detachment. There
have been a number of reports of high levels of cell detachment among the same order
as seen here [15, 25, 62]. The level of cell detachment due to ultrasound exposure alone
(US group) was on the same order as the sham treatment (UCA group) at 37°C. Since
the US+UCA group had significantly higher cell detachment over US alone and UCA
alone, microbubble cavitation may be facilitating cell detachment. In [63], high-pressure
shock waves were used to induce cavitation in an adherent cell culture. Using high-speed
imaging, the authors found that cell detachment only occurred when cavitation activity
was present. The reason for this, they suggested, was that the flow due to the cavitating
bubble near the rigid substrate generated a shear force large enough to remove the cells
from the substrate. Though the rarefactional pressure of the shock waves in [63] was large
enough to induce cavitation without UCA present, a similar effect may have occurred at
a lower pressure amplitude here due to the presence of the UCA.
3.4.3 Effects of temperature
The preliminary study of temperature on sonoporation efficacy resulted in no observ-
able, significant, net-positive effect under our experimental conditions with increased bath
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temperature. There are many actors involved in the sonoporation process which have
temperature-dependent qualities which, together, may affect its efficacy. For instance,
the cavitation of microbubbles is an important factor. Microbubble properties such as
size distribution and stability have been shown to be affected by temperature [56, 57].
In [57], the mean microbubble diameter for SonoVue UCA (phospholipid-shell) was seen
to increase with temperature and, after a few minutes, dropped abruptly. The growth of
the microbubbles was thought to be occurring due to the gas expansion of the bubbles as
well as the reduced surface tension of the shell. The phase transition temperature of the
shell of SonoVue UCA has been noted to be around 40°C [56]. The decreasing stability
with time was attributed to the possibility of a phase change of the shell since a similar
drop was not observed at 37°C. Though the UCA used here (Definity) is not identical,
there may be similarities in its temperature-dependent behaviour. That is, the higher
temperatures may have affected both the microbubble size and stability of the Defin-
ity UCA during treatment. Here, the total treatment time was 7 minutes whereas the
abrupt drop in SonoVue population observed in [57] occurred around 6 minutes. It may
be the case that during the sequential insonations that the properties of the microbubbles
changed between the exposures, affecting the average per-replicate transfection efficiency
and cell detachment at the elevated temperatures.
Temperature-dependent qualities of the cell membrane such as membrane fluidity have
been seen to affect sonoporation efficacy as well. In [44], prostate cancer-derived PC-3 cells
treated with a heat treatment (44°C, 1-minute equalization) showed a 15-fold increase in
the rate of permeability from sonoporation treatment over 37°C. This is in contrast to the
effect observed here. The authors attributed the increase in permeability to an increase in
membrane fluidity as the effect was similar to lidocaine treatment, a substance known to
increase membrane fluidity. The effect of temporal microbubble size and stability in [44]
was likely minimal due to the short per-replicate insonations (1 minute).
Lastly, the magnitude and homogeneity of the acoustic field may have been affected
at the fixed treatment distance due to a change in the speed of sound of the water bath
at higher temperatures. Due to the device’s operation in the near-field region, this effect
would likely be more pronounced than if the treatment distances were closer to the near-
far field transition distance. However, the change in speed of sound due to temperature
from 37°C to 42°C is a relatively small change, approximately 0.53% (1524 m/s v. 1532
m/s [64]).
In order to come to a conclusion on the effect of temperature on sonoporation efficacy
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on SiHa cells, these many factors must be subject of future study.
3.5 Conclusion
The sonoporation platform was observed to be effective at inducing permeability of SiHa
cells at a similar rate to the previous system. The previous system took roughly a half-day
to set-up for experiments (3 to 4 hours). During this study, this new system took on the
order of a half-hour to 1 hour, dominated mainly on the bath treatment time (heating
and degassing). While the operator was not required to manage the acoustic conditions
at the start of each experiment day, the management of the general-purpose electrical





The proposed sonoporation device was designed to have six transducers which were to
be operated automatically. However, standard lab equipment (waveform generators and
amplifiers) typically have a single output. This limits the device to being operated in a
sequential manner. In this case, both the operating transducer and the excitation parame-
ters need to be manually switched between insonations by the operator. It would be ideal
to have an ultrasound excitation device which could support up to six independently-
controlled concurrent excitations. This chapter explores the possibilities for power output
stages for such an electrical driver and the design and simulation of this power output
stage.
4.2 Design Requirements
The electrical output power required to produce the desired acoustic pressure was previ-
ously determined for each transducer at its optimal treatment distance. The maximum
observed output power (123 W) served as a basis for designing power drivers for the
transducer array. The required output power was taken to be 150 W to provide addi-
tional margins for safety, reliability, and flexibility.
A summary of the electrical and acoustic requirements are listed in Table 4.1.
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Center operating frequency 1 MHz
Bandwidth (unspecified)
Output load 50 Ω (f = 1 MHz)
Maximum output power 150 W (C.W.)
Table 4.1: Power output stage requirements for ultrasound excitation device.
4.3 Amplifier Topologies
There are many varieties of power amplifiers (also referred to as power inverters) [65–67].
The two types discussed here are current-mode and switch-mode amplifiers. Both of these
types of amplifier use transistors to convert a low-power signal into a high-power signal.
They differ, however, in their use of transistor(s).
Current-mode amplifier topologies use transistors as controlled current sources [65,67].
These amplifiers are classified based on the portion of the waveform cycle during which
the transistor conducts, referred to in general terms as the conduction angle, θ. Class A
refer to those amplifiers whose transistors conduct during the entire waveform cycle (i.e.,
θ = 2π), Class B refer to those which conduct during a half the cycle (θ = π), and Class
C refer to those which conduct during less than half the cycle (θ < π). Class AB refers
to those amplifiers whose transistors conduct between a half (Class B) and a full (Class
A) waveform cycle (π < θ < 2π) [65, 67].
Switch-mode amplifiers topologies use transistors as switches, either non-conducting
(off) or fully conducting (on) [65, 67]. As a consequence, switch-mode amplifiers are
classified based on topology and operating principle rather than conduction angle [65].
Class D, for example, refers to an amplifier with transistors which are switched on and
off in alternating intervals in order to convert a DC voltage (or current) into a square
AC voltage (or current) waveform [65,67]. The harmonic content of this waveform can be
filtered by a resonant network at the amplifier output in order to produce a sinusoidal out-
put. Class E is another type of switching amplifier which employs zero-voltage switching
(ZVS) and zero-derivative switching (ZDS) conditions [65, 67]. These conditions ensure
that the switch voltage and switch current waveforms are non-overlapping, yielding zero
power dissipation and zero switching loss in the transistors for a theoretical efficiency of
100% [65,67]. Class DE amplifiers refer to those which combine typical Class D topologies
(e.g. half-bridge) with Class E ZVS and ZDS conditions to reduce switching and drain
power losses [65, 67].
Class A amplifiers can be highly linear, similar to a small signal amplifier, amplifying
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Class Mode Max. Efficiency Notes
A Current-mode 50% Low distortion
θ = 2π
B Current-mode 78.5% Cross-over distortion
θ = π
AB Current-mode 78.5% π < θ < 2π
C Current-mode 50-100% Non-linear
θ < π
ηmax = 100%, θ = 0
ηmax = 50%, θ = π
D Switch-mode 100% Inductive load preferred
High-side switching
E Switch-mode 100% ZVS and ZDS conditions
Single switch (low-side)
DE Switch-mode 100% ZVS and ZDS conditions
High-side switching
F Switch-mode 100% Multiple resonators
Complex circuit/analysis
Table 4.2: A summary of power output stage (amplifier) classes [65,67].
an input signal with little distortion [65]. However, Class A suffer from very low practical
efficiencies (e.g. 40-45% [65]). The input signal of switch-mode amplifiers, on the other
hand, are treated as a timing signal rather than a small signal needing to be amplified
undistorted [67]. As a result, switch-mode amplifiers have higher practical efficiencies but
suffer from non-linearity [65,67]. A summary of different classes of amplifiers is provided
in Table 4.2.
4.4 Candidate Amplifier Topology
Class DE half-bridge topology was considered for this application (Fig. 4.1) [67]. The
ultrasound driver to be designed is required to provide a high-power sinusoidal signal of a
single frequency. Switch-mode amplifiers are an efficient way to fulfill these requirements.
Class DE amplifiers provide lower voltage stresses on the transistors than Class E while
providing the same ZVS and ZDS switching conditions. The benefits of Class DE over
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the Class E come at the expense of added switching complexity and a high-side N-channel
MOSFET which is more difficult to drive [67]. An efficient amplifier reduces the size and
cooling requirements, potentially allowing for multiple drivers to be in a smaller device.
While current-mode amplifiers provide better linearity over switch-mode amplifiers,
linearity is important for applications such as ultrasound imaging, where a signal needs
to be amplified with minimal distortion. Linearity is less important in this application as
long as the output power can effectively be controlled.
4.5 Amplifier Design
4.5.1 Design Equations
The design for the Class DE amplifier was adopted from [65] and [67]. The amplifier
topology is shown in Fig. 4.1 and the design equations for a 25% duty cycle are sum-


























Figure 4.1: Class DE half-bridge power amplifier topology [67].
4.5.2 Output Quality Factor
The quality factor of the output network, QL, must be chosen during design to yield prac-
tical component values. One of the design requirements was to support pulsed operation,
hence, a relatively low QL should be chosen to reduce oscillation and additional power
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Output capacitance C =
1
ωRo(QL − π2 )
(4.4)
Table 4.3: Component value equations for a Class DE half-bridge amplifier, k = 0.25 [67].







Maximum drain-source voltage VDS(max) = VI (4.6)




Maximum voltage across series inductor VL(max) = ωLIm(max) (4.8)
Table 4.4: Device stress equations for a Class DE half-bridge amplifier, k = 0.25 [67].
being transferred to the load after each pulse. However, the ability for the output network
to filter higher harmonics decreases (i.e. the bandwidth increases) with decreasing quality





where ∆f is the bandwidth of the output network and fc is its resonant frequency [52]. As
QL decreases, the shape of the output current waveform becomes less sinusoidal and more
exponential, increasing the total harmonic distortion (THD) [67]. Therefore, the choice
of QL was made qualitatively and iteratively during simulation as a trade-off between
damping oscillations and the resulting harmonic power, with transient damping taking
precedence.
4.5.3 Output Impedance Transformation
The switching frequency, output power, and output load resistance have been given to
be 1 MHz, 150 W, and 50 Ω respectively. However, using these values with the design
equations in Table 4.3 may not necessarily yield a practical solution. For example, the
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DC supply voltage becomes 384.7 VDC using (4.1) and the requirements above. Instead,
the DC supply voltage was made a design parameter, yielding an output load resistance
different from that of 50 Ω. From this, an impedance transformation can be applied to










Figure 4.2: Downward split-capacitor impedance transformation. The impedance (Zeq)
for the sections containing Cs-Rs and Cp-Rp can be made equal for a given frequency
(Rp > Rs).
For example, a split-capacitor downward impedance transformation can be applied
[67]. Here, one can take the series capacitor C and split it in two series capacitances Ca
and Cs (Fig. 4.2). Equating the impedances of the resulting series Cs-Rs section to a
parallel Cp-Rp combination yields expressions which can be used to transform the desired
load resistance Rp = 50 Ω into the resultant design load resistance Ro = Rs at the center
operating frequency:
Zs = Zp (4.10)
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)2 = XCp1 + q−2 . (4.16)





− 1 . (4.17)
Note that for q to be a real, Rp > Rs. Additionally, given a desired Rp and a design value
of Rs, the ratio Rp/Rs is defined and, hence, q is defined.































QL − q − π2
) (4.21)
Note that the defined value for q raises the minimum design value of QL.
Since the impedance of the parallel Cp-Rp combination is equal to that of the series
Cs-Rs combination, the voltage across both are equal for the same output current io:
vRp = ioZs (4.22)
The voltage and current stresses in the parallel network can be found using the output
peak current Im(max):
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4.5.4 Analysis






































= 12.4 nF (4.30)
Ca =
1
ωRs(QL − q − π2 )
=
1
(2π(1 MHz))(3.11 Ω)(8− 3.88− π
2
)







= 13.2 nF (4.32)
Device Stresses






= 9.82 A (4.33)
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= 77.8 V (4.35)




























= (122 V) (2π(1 MHz)(12.4 nF))
= 9.51 A (4.39)
4.6 Simulation
4.6.1 Components and SPICE Models
The amplifier was simulated using LTSpice (v4.20h; Linear Technology Corporation).
Some component models were chosen for the simulation at this stage based on the re-
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quirements and analytically determined maximum stresses above.
Switching Components
IRFB5620 (International Rectifier) N-channel MOSFETs were chosen for the switching
components. These MOSFETs are rated for a maximum drain-source voltage of 200 V,
much higher than the maximum computed stress VDS(max) = VI = 96 V. The output
capacitance of the MOSFETs (Co) limit the maximum switching frequency of the amplifier
[67]. The output capacitance is determined by
Co = CDS = COSS − CRSS (4.40)
where CDS is the drain-source (output) capacitance, and COSS and CRSS are values pro-
vided by the manufacturer [66]. For the IRFB5620, Co = CDS ≈ 108 pF, thus, the







= 75.4 MHz . (4.41)
This frequency is well above the operating frequency, f = 1 MHz.
The rated continuous drain current is 25 A at 25 °C and 18 A at 100 °C, well above
IDM(max) = 9.8 A. The reverse-diode current rating is 25 A, or 100 A for short pulses
(the width depending on the junction temperature).
This MOSFET appears to be within the specifications for the amplifier. The SPICE
model for this MOSFET was provided by the manufacturer and used for simulation.
Gate Drivers
SPICE voltage sources were used to simulate gate drivers. These voltage sources were
set-up to deliver a “square” waveform at 1 MHz with 20 ns rise and fall times. These
drivers were given output resistances of 100 mΩ.
Passive Components
Passive components were simulated using the default SPICE models. The reactive compo-
nents were given equivalent series resistances of 100 mΩ, an estimate for ceramic capacitors
and hand-wound inductors.
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Figure 4.3: LTSpice schematic for the Class DE amplifier with a 50 Ω resistive load:
f = 1 MHz, Po = 150 W, and QL = 8.
DC Supply
The DC supply voltage was simulated using a SPICE constant voltage source. The output
resistance of the source was 100 mΩ, lower than the input resistance of the amplifier, in
order to produce a relatively constant supply voltage VI = 96 V during the simulation.
4.6.2 Measurements
Initial simulations were performed using a resistive 50 Ω load (Fig. 4.3). The pulsed
operation of the device (30 cycles at 1 MHz) was used to evaluate the transient behaviour
at the beginning and end of the pulse. The average input power, output power, drain
power, and gate (drive) power, drain efficiency, efficiency, power-added efficiency, gate
drive gain, and total harmonic distortion were each determined over 10 cycles in the
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centre of the pulse as an estimate of their steady-state values. The maximum time step
was set to 10 ns and the operation was simulated for 100 µs.
4.6.3 Adjustments
The MOSFET output capacitance was subtracted from the ideal switch shunt capacitors
Cm. While the datasheet provided a value for this capacitance, an alternative value of
Co = 1.02 nF was found by trail and error. The value of this capacitance was adjusted
in order to minimize the drain-source voltage and resultant spike in drain current at
the moment of switch-on (Fig. 4.4b). (That is to say, equivalently, that the design
value Cm was reduced to produce the desired effect.) As a result, the drain-source shunt
capacitances values became Cm = 8.14 nF − 1.02 nF = 7.12 nF. The large spikes in
current (of nearly 100 A) still remain at the beginning of the pulse due to the non-
zero DC voltage across the transistors during the transient start-up from rest. Taking
Co = 1.02 nF reduces the maximum switching frequency of the amplifier to 7.99 MHz,
still well above the 1 MHz design switching frequency.
4.6.4 Results
The results of the transient simulation of the circuit in Fig. 4.3 are summarized in Table
4.5. The average output power was 139 W, lower than the anticipated design value of
150 W. The average input DC power was 149 W. The average drain powers were 800 mW
for both MOSFETs. Thus, the drain efficiency, given by
ηD =
(




was 98.9% for the measured interval. The average gate drive power was 371 mW and
372 mW for M1 and M2 respectively. The power gain, given by
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was 89.8% and the power added efficiency, which accounts for the input gate drive power,
given by
PAE =


























Figure 4.5: The relative power (dB) of the frequency components of the output voltage
waveform with a resistive 50 Ω load (fc = 1 MHz). The power of the 3rd and 5th
harmonics are -43.2 dB and -71.0 dB respectively.
The total harmonic distortion (THD) of the output voltage over this interval was
33.7%. The 3rd and 5th harmonic powers were -43.2 dB and -71.0 dB respectively (Fig
4.5). A DC component of 3.10 µV was present as well. The THD of the output voltage
could be improved by increasing the quality factor of the output RLC network (QL) at
the expense of slower transients at the start and end of the pulse.
Transients
Ideally, transients at the start and end of the pulse would not exist for a pulsed application.
This would allow the device to deliver a exact number of cycles per pulse. However, due
to the use of reactive components and the high quality factor of the output filter (under-
damped), transients will be present. The resulting output voltage waveform for a single
pulse is plotted in Fig. 4.4d. At the start of the pulse, the envelope of the output voltage
takes less than one cycle to reach 63.2% of the maximum of 118.8 V (i.e., the rise time)
4.7. TRANSDUCER ELECTRICAL MODEL 59
and about 6-7 cycles to reach the maximum. At the end of the pulse, the envelope of the
output voltage takes about 3-4 cycles to fall below 37.8% of the maximum (i.e., the fall
time) and about 18 cycles to fall below 0.1%.
These transient periods are relatively small with respect to the duty cycle. The rise
time is less than 3.33% of the pulse length (30 µs) and the fall time is less than 0.68% of
the dead time (595 µs).















Figure 4.6: Butterworth-Van Dyke electrical model of a piezoelectric transducer.
The simulations in the previous section were repeated, replacing the resistive 50 Ω
load with a model of the transducer. The model used here was the Butterworth-Van Dyke
(BvD) model (Fig. 4.6) [47, 68, 69]. This model is comprised of an electrical capacitance
(C0) in parallel with multiple series resonant branches. Each series resonant branch models
the mechanical oscillation of the piezoelectric element at each odd harmonic. A series
resonant frequency (ωs,n = 2πfs,n) and a parallel (anti-)resonant frequency (ωp,n = 2πfp,n)
exists for each branch, n. At fs,n, the series branch inductance and capacitance cancel
out, leaving the series branch resistance (Rs,n) in parallel with the static capacitance (C0).
The frequency, fs,n can be found when the real part of the measured admittance is at
local maximum (Fig. 4.7) [47]. Similarly, at fp,n, the real part of the impedance is at
local maximum [47]. The model values can be determined using the following equations
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Figure 4.7: The measured impedance (top) and admittance (bottom) for a transducer
from 0.5 MHz to 2 MHz. The series resonant frequency fs occurs on this range where
the real part of the admittance is at a maximum. The parallel (anti-)resonant frequency
fp where the real part of the impedance is at a maximum. Here, fs ≈ 0.995 MHz and
fp ≈ 1.09 MHz.
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Figure 4.8: The resultant Butterworth-Van Dyke model with input inductance and com-






















where Rs,n, Cs,n and Ls,n are the series resonant branch resistance, capacitance, and
inductance respectively, and Ys,n is the total admittance of the model at the series resonant
frequency of the nth branch (ωs,n = 2πfs,n). Upon identifying fs,1, fp,1 and Ys,1, C0 can
be calculated from (4.46). The values Rs,1, Cs,1, and Ls,1 can be determined once C0 is
found using (4.47), (4.48), and (4.49). For additional branches, the same value for C0 can
be used, however, fs,n, fp,n and their corresponding impedances will differ.
4.7.1 Measurements and Computations
Model Modifications
Values for the electrical model were computed from impedance measurements made for one
of the six transducers in a water bath at a temperature of 37°C. The measurements were






















Figure 4.9: The impedance of the model (thin, black) against the measured impedance
(thick, grey) showing good agreement over 0.5 MHz to 6 MHz.
made using an Agilent E5071C network analyser (Agilent Technologies Canada Inc., Mis-
sissauga, ON, Canada). The measured impedance included that of the cable in addition
to the piezoelectric element. In order to fit the BvD model to the measured impedance,
the cable was modelled as an inductive impedance in series with the BvD model and was
subtracted from the measured values prior to computing the model.
The value of the input inductance was iteratively adjusted to achieve the best fit to
the measured data at high frequencies. The optimal input inductance was found to be
750 nH. The modified model and its values are shown in Fig. 4.8. The impedance of the
model is plotted against the measured impedance in Fig. 4.9.
Matching Circuit
In practice, the transducers are electrically matched to 50 Ω at 1 MHz using an L-type
(2-element) matching network. The impedance of the transducer model at 1 MHz was
Z = 48.2 − j8.57 Ω. A low-pass L-type matching network was computed and added to
the simulation.
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From Section 2.5, the condition for matching is
Z∗A = Z1 + Z2‖ZB (4.50)









































(50 Ω)2 − (50 Ω)(48.2 Ω)
(50 Ω)2
= {−0.00386,+0.00386} S (4.54)
and












= {−0.756, 17.9} Ω . (4.55)
Choosing B2 = +0.00386 S (and correspondingly X1 = 17.9 Ω), the component values for















= 615 pF . (4.57)
4.7.2 Simulation
The modified LTSpice circuit is shown in Fig. 4.10. This circuit differs from the resistive
case (Fig. 4.3) only in that the 50 Ω resistive load is replaced with a two-element matching
circuit and a BvD model subcircuit component. The simulation parameters were otherwise
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Figure 4.10: LTSpice schematic for Class DE amplifier with transducer model and L-type,
low-pass matching circuit.
identical to the resistive case described above.
4.7.3 Results
The results of the transient simulations using the BvD model are summarized in Table
4.5. The average output power was 134 W, about 5 W lower than the resistive case. The
average input DC power remained 149 W. Hence, the overall efficiency was 89.5%, a drop
of 0.3% over the resistive case. The average drain powers were 805 mW and 810 mW for
M1 and M2 respectively, a 5-10 mW increase over the resistive case. Nevertheless, the
drain efficiency remained at 98.8%. The average gate drive powers were 363 mW and
364 mW for M1 and M2 respectively. The resultant gain was 22.6 dB, a drop of 0.1 dB
over the resistive case. The power added efficiency was 89.0%, a drop in 0.3%.
The THD due to the transducer model was slightly better at 27.9%, a decrease of 5.8%
over the resistive case. The third and fifth harmonic powers were -43.2 dB (an increase
of 1.4 dB) and -71.7 dB (a decrease of 0.9 dB) respectively (Fig. 4.11). A DC component
of -160 mV was present as well.





















Figure 4.11: The relative power (dB) of the frequency components of the output voltage
waveform using the transducer model (fc = 1 MHz). The power of the 3rd and 5th
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Figure 4.12: (a) The first 80 µs of the resulting output voltage waveform showing ringing lasting for more than 20 cycles
after excitation halted (at 30 µs). (b) The drain-source voltage for the lower switching device (M2) showing the switching
conditions for the first 5 µs of the simulation. (c) The drain current for the lower switching device (M2) showing large,



























Quantity 50 Ω BvD ∆abs ∆rel
Input power (PI) - 149 W 149 W 0 W ±0%
Output power (Po) - 139 W 134 W -5 W -3.60%
Gate drive power (PG) M1 371 mW 363 mW -8 mW -2.15%
M2 372 mW 364 mW -8 mW -2.15%
Drain power (PD) M1 800 mW 805 mW +5 mW +0.625%
M2 800 mW 810 mW +10 mW +1.25%
Gate power gain (GdB) - 22.7 dB 22.6 dB -0.1 dB -1.43%
Drain efficiency (ηD) - 98.9% 98.8% -0.1% -0.101%
Efficiency (η) - 89.8% 89.5% -0.3% -0.334%
Power-added efficiency (PAE) - 89.3% 89.0% -0.3% -0.336 %
Total harmonic distortion - 33.7% 27.9% -5.8% -17.2%
DC 3.10 µV -0.16 V ∼ -0.16 V 5.16× 106%
3rd harmonic -44.6 dB -43.2 dB +1.4 dB +3.14%
5th harmonic -70.8 dB -71.7 dB -0.9 dB -1.27%
Pulse rise-time 63.2% 1 cycles 2 cycles +1 cycle +100%
Pulse fall-time 37.8% 4 cycles 8 cycles +4 cycles +100%
0.1% 19 cycles 86 cycles +67 cycles +352%
Table 4.5: LTSpice simulation results showing measured quantities for the 50 Ω case, the transducer model (BvD) case,
and the absolute and relative changes when using the transducer model.
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The transients at the output at the start and end of the pulse differed greatly from
those in the resistive case (Fig. 4.12). The start-up transient was much less damped. The
first peak of the output voltage occurs after 2 cycles but swings back down below 100 V
on the 5th cycle before rising again (Fig. 4.12a). The fall time after the pulse extends well
beyond that of the resistive case. The envelope of the waveform falls below 37.7% after
approximately 7-8 cycles, compared to 3-4 in the resistive case.
4.7.4 Discussion
Transducer Damping
The quality factor of the transducer model is fairly high. For example, the quality factor










= 13.6 . (4.58)
The Q of this branch is much higher than that of the output network of the amplifier
(Q = 8). Thus, between the two, the one with the larger Q (i.e., the transducer) will
dictate how long the voltage will oscillate after each pulse [52]. If the amount of ringing
is satisfactory, then it is possible to redesign the amplifier with an output network with
a quality factor closer to that of the transducer without it affecting too much the output
waveform, possibly improving the THD. If not, it may be necessary to provide damping
to the piezoelectric crystal. This can be done either by adding a backing or matching
layer into the transducer design, which will dampen the mechanical oscillation, or by
electrically loading the piezoelectric element [47,48]. Both may be worth exploring as an
option in the future.
Switching Conditions
The voltages across the switching components were affected by the use of the BvD model
over the 50 Ω resistive load. Like the resistive case, the drain-source voltage across the
lower switching component was high at the beginning of the pulse due to the rest state
of the amplifier at the start of the pulse, but nears zero after only a few cycles (Fig.
4.10b). However, unlike the resistive case, a negative drain current develops for the low-
side MOSFET after only a few cycles, just prior to the turn-on of the device (Fig. 4.10c).
This negative current may be due to the body diode of the MOSFET is turning on as the
voltage at the input of the RLC resonant network (i.e., the drain-source voltage) may be
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dropping below 0 V (Fig. 4.12b). While this diode clamps the voltage at one diode drop
below 0 V, the large reverse current may shorten the life of the switching component. In
the resistive case, the values for the shunt capacitors were adjusted to minimize the spike
in current at turn-on of the MOSFETs. It may be possible to reduce the negative drain
current at turn-on in the same manner. Other tuning strategies are available for Class
DE amplifiers as well, one of which controls the phase of the output voltage and current




The goal of this project was to build a system to reduce the time and expertise required
to perform sonoporation on adherent cells in monolayer. In addition to platform (Chapter
2) and the power driver (Chapter 4), the vision for this system included driving circuitry,
output power control, water treatment, and experimental control. Hence, there remain a
number of components of the system that can be considered for future work.
5.1 Power Control
The next stages of work for the power driver are the design of the input DC power and
power control circuitry (Fig. 5.1). In order to expose cells at a given pressure, the
electrical power delivered to each transducer needs to be controlled. The electrical output
power of the Class DE drivers can be controlled directly by controlling the DC supply
Name Typ. Power Notes
Buck <100 W Regulator
Boost <100 W Regulator
Buck-boost <100 W Regulator
Flyback 100-200 W Converter; transformer
Forward 100-200 W Converter; transformer
Half-bridge 200-400 W Converter; complex switching
Full-bridge >400 W Converter; complex switching
Table 5.1: A summary of DC-DC converter topologies [70].























Figure 5.1: A block diagram illustrating an ultrasound power driver, including the power
supply and power control configuration.





To control the DC supply voltage, it will be necessary to design and build a power regula-
tor, such as a DC-DC power converter [71–73]. It may be sufficient to monitor and control
the DC supply voltage, thereby affecting the output power, rather than monitoring and
controlling the output power directly. However, the required DC supply voltage to get a
desired output power needs to be calibrated at some time before experiments, requiring a
sense of the output power. A brief summary of possible DC-DC regulators and converters
was compiled from [70] and is available in Table 5.1.
5.2 Experimental Control
An experimental controller can be made to provide an easy-to-use user interface to the
system for setting up experimental parameters, automate as much of the experiment and
set-up as possible by communicating with the different system components, log experi-
mental parameters and error messages, and display information, warnings, or errors to
the user.
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The experimental parameters that are not strictly fixed (but may have hardware limits)
are bath temperature, pulse duration, pulse repetition frequency, and output electrical
power. These parameters could potentially be configured by the user in a well-integrated
system. Additionally, acoustic parameters can potentially be specified on a per-transducer
basis if, for example, the user wanted to expose different sections of the cell culture to
different acoustic parameters. This operation would have the benefit of allowing one to
produce multiple biological replicates under a variety of acoustic conditions rather than
multiple “pseudo-replicates” exposed under a single set of conditions, while maintaining
the same material requirements.
The most hardware-dependent parameter of the system is the ultrasound operating
frequency. The piezoelectric elements of the transducers were cut for a specific operating
frequency. To change the operating frequency, the transducers may need to be redesigned
with different piezoelectric elements or may be driven at their odd harmonics. The ampli-
fier and matching circuits were designed to both operate at a single switching frequency
and the output of the amplifier is designed to minimize much of the harmonic content
of the output. Thus, to change the operating frequency of the system would require re-
peating much of the work presented here, for the new frequency, or designing broadband
electrical components.
5.3 Water Treatment
Water treatment, such as degassing and heating, could be integrated into the experimen-
tal control or left as separate systems. Commercial degassing options include Liqui-Cel
(Membrana-Charlotte, Charlotte, NC, USA) and PermSelect (PermSelect, Ann Arbor,
MI, USA). Commercial bath-heating options are available as well, including those avail-
able from PolyScience (PolyScience, Niles, IL, USA).
5.4 Transducer Damping for Pulsed Operation
The quality factor of the transducer model at 1 MHz was fairly high (13.6). This poses a
problem when operating pulsed mode [48] since the transducer will continue to oscillate
after excitation, affecting both the operation of the power driver as well as the acous-
tic exposure during sonoporation treatments. Taking a more detailed approach to the
transducer design may be part of some future work. Broadening the frequency response
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of piezoelectric elements (i.e., improving pulsed operation) has been performed both me-
chanically, by adding quarter-wave-length matching layers to the front-side of air-backed
transducers [74], and electrically, using lumped broad-band equalizer circuits [75,76]. Ad-
ditional information on broadband transducers for imaging and their design are available
from [47] and [77].
5.5 Near-focus Operation
The acoustic near-field was chosen as the operating region for the sonoporation platform
in order to reduce the height of the device. However, this need was based on the choice
of a 20 mm diameter piezoelectric element – a choice which resulted from consultation
with the manufacturer based on the acoustic requirements. It may be possible to achieve
a similar treatment distance (i.e., device height) with elements of half the size (10 mm
in diameter). The near-far field transition distance for such an ideal device would be
approximately 16.6 mm. The benefits of pursuing this design change include wider, more




Modes of Operation of a Half-Bridge
Class DE Switch-Mode Amplifier
A.1 Circuit Description
The Class DE amplifier described in [67] is a half-bridge topology (Fig. A.1). The two
switching components are driven to saturation in an alternating fashion where the top
device is switched on at ωt = 0, the bottom device is switched on at ωt = π, and each
device is on no longer than half the period (k = ∆ωt
2π
< 0.5). Hence, there exists a dead-
time between each device switching off and the next switching on where two switch-shunt
capacitors charge or discharge, both supplying the output current and shaping the voltages
across the switching components. The design of the amplifier is such that the zero-
voltage switching (ZVS) and zero-derivative switching (ZDS) conditions are satisfied at
the time of turn-on of each switching device. The output consists of a tuned RLC network
of sufficiently high quality-factor, such that the output current waveform is assumed
sinusoidal. Here, the design equations are derived for the case of k = 0.25 (equal switching
and dead-times) [67].
A.2 Assumptions
1. All switches are assumed ideal, having zero switching times, zero on-state resistance,
and infinite off-state resistance.
2. The quality factor of the output RLC network QL is sufficiently high, such that the


























Figure A.1: Class DE power amplifier topology [67].
output current is considered sinusoidal, i.e., io = Imsin(ωt+ φ).
3. Each switch is on for one-quarter of the period (k = 0.25) with the top switching
component switching on at ωt = 0 and the bottom switching component switching
on at ωt = π.
A.3 Modes of Operation
The DE topology shown in Figure A.1 has four modes of operation.
Mode 1: S1 on/S2 off
This mode begins with S1 switching on.
vDS1 = 0 (A.1)



















































Figure A.2: The waveforms for Class DE power amplifier with duty cycle of k = 0.25,
corresponding to voltages and currents in Fig. A.1.
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Thus, the output current, io = Im sin(ωt+ φ), is carried by S1
io = iC1 − iC2 + iS1 − iS2 (A.7)
io = 0− 0 + iS1 − 0 (A.8)
io = iS1 (A.9)
iS1 = Im sin(ωt+ φ) (A.10)
Mode 2: S1 off/S2 off
This mode begins with S1 switching off:











Since both switching devices are off, the output current is carried by the capcitors C1 and
C2:
io = iC1 − iC2 + iS1 − iS2 (A.14)
io = iC1 − iC2 + 0 + 0 (A.15)































APPENDIX A. MODES OF OPERATION OF A HALF-BRIDGE CLASS DE
SWITCH-MODE AMPLIFIER
At the start of mode 3, S2 will switch on. The design requires the voltage across the





















sin(π + φ) = 0 (A.24)
sin(π + φ) = 0 . (A.25)
Two solutions exist: φ = 0 and φ = π. Since C1 is charging and C2 is discharging during
this interval, the only physical result is
φ = 0 . (A.26)
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As a result, vDS2 simplies to




vDS2 = VI + VI cos(ωt) (A.35)
vDS2 = VI [1 + cos(ωt)] . (A.36)
Mode 3: S1 off/S2 on
This mode begins with S2 switching on:
vDS1 = VI (A.37)













The output current is carried by S2:
io = iC1 − iC2 + iS1 − iS2 (A.41)
io = 0− 0 + 0− iS2 (A.42)
iS2 = −io (A.43)
iS2 = −Im sin(ωt) (A.44)
Mode 4: S1 off/S2 off
This mode begins with S2 switching off.
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The output current is carried by capacitors C1 and C2:
io = iC1 − iC2 + iS1 − iS2 (A.47)
io = iC1 − iC2 + 0− 0 (A.48)






















































Integrating (A.55) to get vDS1,






















































vDS1 = VI − VI cos(ωt) (A.66)
vDS1 = VI [1− cos(ωt)] (A.67)
and
vDS2 = VI − vDS1 (A.68)
vDS2 = VI cos(ωt) . (A.69)
Since the DC current through the switch shunt capacitor is zero at steady state op-
eration, the DC supply current develops as a result of the switching components. Thus,
the average (DC) input current is
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A.4 Component Values and Stresses
Here, the amplifier will be operating above resonance (i.e., inductive) at its operating
frequency ω. That is, L = La + Lb where C resonantes with La at ω (Fig. A.1). Addi-
tionally, it is assumed that the output network filters the harmonic components of vDS2,
hence, the fundamental component of vDS2 is
vLb + vRo = VLbm cos(ωt) + Vm sin(ωt) (A.77)
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SWITCH-MODE AMPLIFIER
Consequently, the resonanting components become
























ωRo(QL − π2 )
. (A.92)















Po = PI (A.95)

















The design equations for the Class DE amplifier for k = 0.25 are summarized in Tables
A.1 (component values) and A.2 (device stresses).
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Output capacitance C =
1
ωRo(QL − π2 )
(A.103)
Table A.1: Component value equations for a Class DE half-bridge amplifier, k = 0.25 [67].







Maximum drain-source voltage VDS(max) = VI (A.105)




Maximum voltage across series inductor VL(max) = ωLIm(max) (A.107)
Table A.2: Device stress equations for a Class DE half-bridge amplifier, k = 0.25 [67].
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